CUFFA, Bianca
 Distribuzione geografica
Continente #
EU - Europa 272
NA - Nord America 117
AS - Asia 69
SA - Sud America 15
Totale 473
Nazione #
US - Stati Uniti d'America 117
DE - Germania 89
IT - Italia 61
FI - Finlandia 55
RU - Federazione Russa 45
SG - Singapore 44
CN - Cina 17
BR - Brasile 14
IE - Irlanda 9
AT - Austria 7
CZ - Repubblica Ceca 4
HK - Hong Kong 4
IN - India 2
GB - Regno Unito 1
LK - Sri Lanka 1
NL - Olanda 1
PE - Perù 1
UZ - Uzbekistan 1
Totale 473
Città #
Munich 86
Helsinki 45
Ashburn 26
Chandler 20
Singapore 17
Naples 16
Princeton 15
Dublin 7
Jyväskylä 7
Milan 7
Ann Arbor 5
Rome 5
Tianjin 5
Beijing 4
Brno 4
Fisciano 4
Hong Kong 4
Salerno 4
Vienna 4
Castellammare di Stabia 3
Moscow 3
Nuremberg 3
Seattle 3
Turin 3
Washington 3
Andover 2
Boardman 2
Bologna 2
Fairfield 2
Palermo 2
Pune 2
Shanghai 2
Verona 2
Arequipa 1
Arienzo 1
Betim 1
Brasília 1
Cambridge 1
Dallas 1
Divinópolis 1
Dongguan 1
Dracena 1
Inhumas 1
Itabira 1
Jacksonville 1
Jiaozuo 1
Juiz de Fora 1
Jundiaí 1
Kandy 1
Lappeenranta 1
Messina 1
Nola 1
Quirinópolis 1
Sant'antimo 1
Scisciano 1
Siena 1
Sumaré 1
São Bernardo do Campo 1
São Paulo 1
Tashkent 1
Três Marias 1
Uberlândia 1
Villaverla 1
Wilmington 1
Yubileyny 1
Totale 351
Nome #
Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma 168
Therapeutic drug monitoring might identify poor responders to ruxolitinib treatment in myeloproliferative neoplasms 71
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 58
A case series of blastic plasmacytoid dendritic cell neoplasia 43
Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies 31
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 31
Inter-intra instrument comparison and standardization of a 10-color immunophenotyping for B and T cell non-Hodgkin lymphoma diagnosis and monitoring 29
DECREASED LOW-DENSITY GRANULOCYTES AS POSSIBLE DIAGNOSTIC MARKERS OF MYELODYSPLASTIC SYNDROMES WITH EXCESS OF BLASTS 20
Transient Daratumumab-Induced Refractive Shift in Multidrug-Resistant Multiple Myeloma: Case Report and Literature Review 19
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience 18
Totale 488
Categoria #
all - tutte 2.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.381


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 4 0 1 2 2 1 1 2 10 3 0
2021/202227 0 0 2 1 0 0 0 0 2 2 9 11
2022/202357 4 7 12 6 1 11 2 3 4 0 1 6
2023/202486 14 3 8 8 7 15 4 5 7 2 2 11
2024/2025292 8 2 0 5 18 36 114 40 57 12 0 0
Totale 488